Companies / Revolution Medicines, Inc.
Revolution Medicines, Inc.
Financials · FY2025
Ownership
214.3M shares outstanding · as of Jul 31, 2026
Ownership
| Insiders | 1.39% | 2,975,203 |
| Institutions | 94.87% | 203,346,235 |
| Public float | 3.74% | 8,014,980 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 11
View all →| Insider | % of shares | Shares |
|---|---|---|
Borisy AlexisDirector | 1.09% | 2,340,075 |
Goldsmith Mark aSee Remarks · Director | 0.15% | 331,754 |
Kelsey Stephen MichaelFormerSee Remarks | 0.14% | 295,398 |
Horn Margaret AChief Operating Officer | 0.07% | 154,647 |
Anders JackChief Financial Officer | 0.06% | 125,512 |
Wang XiaolinFormerSee Remarks | 0.05% | 116,063 |
Wei LinFormerChief Medical Officer | 0.05% | 101,366 |
Cislini JeffFormerGeneral Counsel | 0.03% | 58,518 |
Mancini AnthonyFormerSee Remarks | 0.03% | 54,400 |
Anderson Elizabeth MDirector | 0.01% | 23,215 |
Institutional holders 421
View all →| Holder | Value | % of shares |
|---|---|---|
| $2.56B | 6.39% | |
| $1.33B | 7.80% | |
| $1.16B | 6.80% | |
| $949.54M | 4.56% | |
| $929.26M | 4.46% | |
| $917.12M | 2.28% | |
| $684.03M | 4.01% | |
| $605.43M | 3.55% | |
| $556.57M | 3.26% | |
| $551.84M | 1.37% |
Activity
InsidersInstitutions
What insiders are doing in this stock (Form 4).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Apr 15, 2026 | Goldsmith Mark a Executive | Sell | Common Stock | $18.01M | -120K -30.25% | 276,698 0.13% of shares | high |
| Jun 15, 2026 | Horn Margaret A Executive | Sell | Common Stock | $9.67M | -60K -27.63% | 158,222 0.07% of shares | medium |
| Jan 7, 2026 | Horn Margaret A Executive | Sell | Common Stock | $5.31M | -53K -24.58% | 162,957 0.08% of shares | medium |
| Jun 17, 2026 | Horn Margaret A Executive | Sell | Common Stock | $4.74M | -30K -16.07% | 154,647 0.07% of shares | medium |
| Jan 7, 2026 | Horn Margaret A Executive | Exercise | Common Stock | $2.18M | +51K +36.44% | 192,459 0.09% of shares | low |
| Jan 7, 2026 | Horn Margaret A Executive | Sell | Common Stock | $2.06M | -20K -12.40% | 142,753 0.07% of shares | medium |
| Mar 25, 2026 | Mancini Anthony Executive | Sell | Common Stock | $2.01M | -21K -24.26% | 65,836 0.03% of shares | medium |
| Jun 16, 2026 | Goldsmith Mark a Executive | Sell | Common Stock | $1.56M | -10K -3.61% | 267,330 0.12% of shares | medium |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Vanguard Group Inc | Passive13G/A | — |
| Farallon Capital Partners, L.P. | Passive13G/A | — |
| Baker Bros. Advisors LP | Passive13G/A | — |
| Wellington Management Group LLP | Passive13G/A | — |
| Janus Henderson Group PLC | Passive13G/A | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| RVMD | — | 76155X100 |